These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7932553)

  • 21. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
    Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
    J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists.
    Ennis MD; Hoffman RL; Ghazal NB; Olson RM; Knauer CS; Chio CL; Hyslop DK; Campbell JE; Fitzgerald LW; Nichols NF; Svensson KA; McCall RB; Haber CL; Kagey ML; Dinh DM
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2369-72. PubMed ID: 12824036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
    Russell MG; Matassa VG; Pengilley RR; van Niel MB; Sohal B; Watt AP; Hitzel L; Beer MS; Stanton JA; Broughton HB; Castro JL
    J Med Chem; 1999 Dec; 42(24):4981-5001. PubMed ID: 10585208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.
    Lima L; Laporte AM; Gaymard C; Spedding M; Mocaër E; Hamon M
    J Neural Transm (Vienna); 1997; 104(10):1059-75. PubMed ID: 9503258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic ergoline derivatives.
    Mantegani S; Brambilla E; Caccia C; Damiani G; Fornaretto MG; McArthur RA; Varasi M
    Bioorg Med Chem Lett; 1998 May; 8(9):1117-22. PubMed ID: 9871719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
    Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
    J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
    Nichols DE; Frescas S; Marona-Lewicka D; Huang X; Roth BL; Gudelsky GA; Nash JF
    J Med Chem; 1994 Dec; 37(25):4346-51. PubMed ID: 7996545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
    Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists.
    Kakigami T; Usui T; Tsukamoto K; Kataoka T
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):42-52. PubMed ID: 9468636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties.
    Laban U; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE
    Bioorg Med Chem Lett; 2001 Mar; 11(6):793-5. PubMed ID: 11277522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B
    Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes.
    Jacobs RT; Brown FJ; Cronk LA; Aharony D; Buckner CK; Kusner EJ; Kirkland KM; Neilson KL
    J Med Chem; 1993 Feb; 36(3):394-409. PubMed ID: 8381184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A-ring ortho-disubstituted aporphine derivatives as potential agonists or antagonists at serotonergic 5-HT1A receptors.
    Cannon JG; Flaherty PT; Ozkutlu U; Long JP
    J Med Chem; 1995 May; 38(11):1841-5. PubMed ID: 7783115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.